Organigram Global (OGI) Cash & Equivalents (2018 - 2026)

Organigram Global (OGI) has reported Cash & Equivalents for 9 consecutive years, with $3.1 million the latest figure, recorded in Q1 2026.

• Quarterly Cash & Equivalents changed N/A year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (changed N/A YoY) and the FY2025 annual result came in at $5.4 million, changed N/A from the prior year.
• Cash & Equivalents retreated to $3.1 million in Q1 2026 per OGI's latest filing, from $5.4 million in the prior quarter.
• Over the last five years, Cash & Equivalents for OGI reached as high as $97.2 million in Q3 2024 and fell as low as $3.1 million in Q1 2026.
• A 5-year average of $30.9 million and a median of $20.7 million in 2022 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2024 — Cash & Equivalents jumped 151.78% — and 2025, when it plunged 78.92%.
• Year by year, Cash & Equivalents stood at $20.8 million in 2022, then jumped by 85.38% to $38.6 million in 2023, then soared by 151.78% to $97.2 million in 2024, then plunged by 94.41% to $5.4 million in 2025, then sank by 42.39% to $3.1 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $3.1 million, $5.4 million, and $20.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.